Conversation with The Cancer LetterFree A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease September 17, 2024Vol.50 No.35By Paul Goldberg
Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis showsSubgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies September 13, 2024Vol.50 No.34By McKenzie Prillaman
Tumors are able to form with no DNA mutations, fly study shows September 13, 2024Vol.50 No.34By Jacquelyn Cobb
FreeObituary Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87 September 13, 2024Vol.50 No.34By Paul Goldberg
Guest Editorial From clinician scientist to nonprofit CEO September 13, 2024Vol.50 No.34By E. Anders Kolb
Trials & Tribulations A simple intervention could help address overlooked pain among older adults with cancer in rural America September 13, 2024Vol.50 No.34By Megan J. Shen
Conversation with The Cancer Letter Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays September 06, 2024Vol.50 No.33By Paul Goldberg
NCI As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5BRathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” September 06, 2024Vol.50 No.33By Jacquelyn Cobb
